查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1387183

心导管电气烧灼术市场报告：2030 年趋势、预测与竞争分析

Cardiac Ablation Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

心导管电气烧灼术趋势和预测

预计到 2030 年，全球心导管电气烧灼术市场将达到 89 亿美元，2024 年至 2030 年年复合成长率为 13.0%。这个市场的主要驱动因素是心血管患者数量众多、医疗基础设施的改善导致人们对更好的医疗服务的意识增强，以及久坐生活方式的采用。全球心导管电气烧灼术市场的未来前景广阔，外科中心、心臟中心和医院市场充满机会。

心导管电气烧灼术市场洞察

Lucintel 预测，由于越来越多地采用先进的治疗方法来治疗慢性心臟疾病，电消融器将在预测期内实现最高的成长。

由于新兴经济体越来越多地寻求有效的治疗解决方案，心臟中心仍然是市场中最大的部分。

由于人口老化迅速增加、心血管疾病盛行率上升以及该地区医疗保健产业的成长，预计亚太地区将在预测期内实现最高成长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2. 未来哪个细分市场成长较快？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球心导管电气烧灼术市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球心导管电气烧灼术市场趋势（2018-2023）与预测（2024-2030）
  • 按产品分類的全球心导管电气烧灼术市场
    • 无线电频率
    • 烧蚀器
    • 电烧灼
    • 冷冻装置
    • 超音波消融仪
  • 按方法分類的全球心导管电气烧灼术市场
    • 导管底座
    • 切开/手术
  • 按最终用途分類的全球心导管电气烧灼术市场
    • 手术中心
    • 心臟中心
    • 医院
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球心导管电气烧灼术市场区域分布
  • 北美心导管电气烧灼术市场
  • 欧洲心导管电气烧灼术市场
  • 亚太心导管电气烧灼术市场
  • 其他区域心导管电气烧灼术市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按产品分類的全球心导管电气烧灼术市场成长机会
    • 全球心导管电气烧灼术市场成长机会（按方法）
    • 按最终用途分類的全球心导管电气烧灼术市场成长机会
    • 按地区分類的全球心导管电气烧灼术市场成长机会
  • 全球心导管电气烧灼术市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球心导管电气烧灼术市场的产能
    • 全球心导管电气烧灼术市场的合併、收购和合资企业
    • 认证和许可

第7章主要企业概况

  • lcon Laboratories
  • Advanced Cardiac Therapeutics
  • Angiodynamics
  • Atricure
  • Biosense Webster
  • Boston Scientific Corporation
  • Conmed Corporation
  • Medtronic
  • Olympus Corporation
简介目录

Cardiac Ablation Trends and Forecast

The future of the global cardiac ablation market looks promising with opportunities in the surgical center, cardiac center, and hospital markets. The global cardiac ablation market is expected to reach an estimated $8.9 billion by 2030 with a CAGR of 13.0% from 2024 to 2030. The major drivers for this market are large population base of cardiovascular patients, increasing awareness about better healthcare services with improving healthcare infrastructure, and growing adoption of sedendary lifestyle.

A more than 150-page report is developed to help in your business decisions.

Cardiac Ablation by Segment

The study includes a forecast for the global cardiac ablation by product, approach, end use, and region.

Cardiac Ablation Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Radiofrequency
  • Ablators
  • Electrical Ablators
  • Cryoablation Devices
  • Ultrasound Ablators

Cardiac Ablation Market by Approach [Shipment Analysis by Value from 2018 to 2030]:

  • Catheter-Based
  • Open/Surgical

Cardiac Ablation Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Surgical Centers
  • Cardiac Centers
  • Hospitals
  • Others

Cardiac Ablation Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Cardiac Ablation Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cardiac ablation companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cardiac ablation companies profiled in this report include-

  • Icon Laboratories
  • Advanced Cardiac Therapeutics
  • Angiodynamics
  • Atricure
  • Biosense Webster
  • Boston Scientific Corporation
  • Conmed Corporation
  • Medtronic
  • Olympus Corporation

Cardiac Ablation Market Insights

Lucintel forecasts that electrical ablators is expected to witness highest growth over the forecast period due to growing adoption of advanced therapeutic procedures to treat chronic cardiac disease.

Within this market, cardiac centers will remain the largest segment due to rising deployment across developing economies for effective treatment solutions.

APAC is expected to witness highest growth over the forecast period due to surge in geriatric population, rising prevalence of cardiovascular diseases, and growing healthcare sector in the region.

Features of the Global Cardiac Ablation Market

Market Size Estimates: Cardiac ablation market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cardiac ablation market size by product, approach, end use, and region in terms of value ($B).

Regional Analysis: Cardiac ablation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, approachs, end uses, and regions for the cardiac ablation market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cardiac ablation market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the cardiac ablation market size?

Answer: The global cardiac ablation market is expected to reach an estimated $8.9 billion by 2030.

Q2. What is the growth forecast for cardiac ablation market?

Answer: The global cardiac ablation market is expected to grow with a CAGR of 13.0% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the cardiac ablation market?

Answer: The major drivers for this market are large population base of cardiovascular patients, increasing awareness about better healthcare services with improving healthcare infrastructure, and growing adoption of sedendary lifestyle.

Q4. What are the major segments for cardiac ablation market?

Answer: The future of the cardiac ablation market looks promising with opportunities in the surgical center, cardiac center, and hospital markets.

Q5. Who are the key cardiac ablation market companies?

Answer: Some of the key cardiac ablation companies are as follows:

  • Icon Laboratories
  • Advanced Cardiac Therapeutics
  • Angiodynamics
  • Atricure
  • Biosense Webster
  • Boston Scientific Corporation
  • Conmed Corporation
  • Medtronic
  • Olympus Corporation

Q6. Which cardiac ablation market segment will be the largest in future?

Answer: Lucintel forecasts that electrical ablators is expected to witness highest growth over the forecast period due to growing adoption of advanced therapeutic procedures to treat chronic cardiac disease.

Q7. In cardiac ablation market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to surge in geriatric population, rising prevalence of cardiovascular diseases, and growing healthcare sector in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the cardiac ablation market by product (radiofrequency, ablators, electrical ablators, cryoablation devices, and ultrasound ablators), approach (catheter-based and open/surgical), end use (surgical centers, cardiac centers, hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cardiac Ablation Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Cardiac Ablation Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Cardiac Ablation Market by Product
    • 3.3.1: Radiofrequency
    • 3.3.2: Ablators
    • 3.3.3: Electrical Ablators
    • 3.3.4: Cryoablation Devices
    • 3.3.5: Ultrasound Ablators
  • 3.4: Global Cardiac Ablation Market by Approach
    • 3.4.1: Catheter-Based
    • 3.4.2: Open/Surgical
  • 3.5: Global Cardiac Ablation Market by End Use
    • 3.5.1: Surgical Centers
    • 3.5.2: Cardiac Centers
    • 3.5.3: Hospitals
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Cardiac Ablation Market by Region
  • 4.2: North American Cardiac Ablation Market
    • 4.2.2: North American Cardiac Ablation Market by End Use: Surgical Centers, Cardiac Centers, Hospitals, and Others
  • 4.3: European Cardiac Ablation Market
    • 4.3.1: European Cardiac Ablation Market by Product: Radiofrequency, Ablators, Electrical Ablators, Cryoablation Devices, and Ultrasound Ablators
    • 4.3.2: European Cardiac Ablation Market by End Use: Surgical Centers, Cardiac Centers, Hospitals, and Others
  • 4.4: APAC Cardiac Ablation Market
    • 4.4.1: APAC Cardiac Ablation Market by Product: Radiofrequency, Ablators, Electrical Ablators, Cryoablation Devices, and Ultrasound Ablators
    • 4.4.2: APAC Cardiac Ablation Market by End Use: Surgical Centers, Cardiac Centers, Hospitals, and Others
  • 4.5: ROW Cardiac Ablation Market
    • 4.5.1: ROW Cardiac Ablation Market by Product: Radiofrequency, Ablators, Electrical Ablators, Cryoablation Devices, and Ultrasound Ablators
    • 4.5.2: ROW Cardiac Ablation Market by End Use: Surgical Centers, Cardiac Centers, Hospitals, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Cardiac Ablation Market by Product
    • 6.1.2: Growth Opportunities for the Global Cardiac Ablation Market by Approach
    • 6.1.3: Growth Opportunities for the Global Cardiac Ablation Market by End Use
    • 6.1.4: Growth Opportunities for the Global Cardiac Ablation Market by Region
  • 6.2: Emerging Trends in the Global Cardiac Ablation Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Cardiac Ablation Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cardiac Ablation Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: lcon Laboratories
  • 7.2: Advanced Cardiac Therapeutics
  • 7.3: Angiodynamics
  • 7.4: Atricure
  • 7.5: Biosense Webster
  • 7.6: Boston Scientific Corporation
  • 7.7: Conmed Corporation
  • 7.8: Medtronic
  • 7.9: Olympus Corporation